TITLE:
Compassionate Use of Stanate (TM) [Stannsoporfin]

CONDITION:
Neonatal Jaundice

INTERVENTION:
Stanate (TM) [stannsoporfin, tin-mesoporphyrin]

SUMMARY:

      The purpose of this protocol is to make Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
      available to infants who meet the following criteria:

        1. the infant has a very high level of bilirubin without an adequate clinical response to
           phototherapy;

        2. the infant requires an exchange transfusion; and

        3. the family refuses to allow the administration of blood products, particularly on
           religious grounds, such as within the Jehovah's Witness community.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: N/A to 1 Week
Criteria:

        -  Term or near term neonate

          -  Elevated serum bilirubin

          -  Failing phototherapy

          -  Requires exchange transfusion

          -  Family refuses exchange transfusion on religious grounds
      
